about
International network of cancer genome projects.The asthma consultative process: a collaborative approach to integrating genomics into public health practice.Recommendations for returning genomic incidental findings? We need to talk!If you build it, they will come: unintended future uses of organised health data collectionsExploring pathways to trust: a tribal perspective on data sharingPharmacogenomics in diverse practice settings: implementation beyond major metropolitan areasThe path from genome-based research to population health: development of an international public health genomics networkThe OHRP and SUPPORTAmerican Cancer Society guidelines for breast screening with MRI as an adjunct to mammographyReturn of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) NetworkInformed Consent in Genome-Scale Research: What Do Prospective Participants Think?Offering aggregate results to participants in genomic research: opportunities and challengesGenomic research and wide data sharing: views of prospective participantsCarnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data.Actionable exomic incidental findings in 6503 participants: challenges of variant classificationReturn of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).Reconsidering the family history in primary careGlad you asked: participants' opinions of re-consent for dbGap data submissionDiabetes and HFE mutations: cause or coincidence?Clinical and public health implications of emerging genetic technologies.Population description and its role in the interpretation of genetic association.Debating clinical utilityReturn of results: ethical and legal distinctions between research and clinical care.Genetic tests: clinical validity and clinical utilityReturn of genomic results to research participants: the floor, the ceiling, and the choices in between.Native Hawaiian views on biobanking.The rules remain the same for genomic medicine: the case against "reverse genetic exceptionalism".Predictors of recruited melanoma families into a behavioral intervention project.Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromesNational Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancerPharmacogenetic research in partnership with American Indian and Alaska Native communities.Health system implications of direct-to-consumer personal genome testingNewborn screening technology: proceed with caution.Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Adding pharmacogenetics information to drug labels: lessons learned.A call for accurate pharmacogenetic labeling: telling it like it isGenetics education for primary-care providers.The translational potential of research on the ethical, legal, and social implications of genomicsGenetic test evaluation: information needs of clinicians, policy makers, and the public.Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group
P50
Q24611474-266B8BB3-4ACB-455E-B5F2-5FBBD82F1B36Q25255655-AE1B7FAF-7089-4086-8781-486A1EC14025Q26995124-7B9FCB74-DF38-4996-99CC-740087C9621CQ27007763-2B63CBFC-DB0C-4DDB-90BC-DA62B379619FQ27008503-BBAABF63-F737-43F7-9305-50F9BF738E62Q27335306-801857F8-0A45-4E50-8D03-B502715B945CQ28252405-68E60A8C-6AB7-450D-941B-30B265B1E06DQ28292121-2AD4AE6F-7EB3-4E18-BDC6-4468D4763CF3Q28295438-412240DE-2709-40FD-8500-46FC1EEBF67EQ28673413-431D5D52-46B4-444B-A7AD-AE5A5DC448CCQ28704258-9337B99F-1492-4B2B-B88E-84995F0CBA75Q28709472-A496D736-E5EB-4A0C-A9BB-385EC6568146Q28742349-9314F9E2-A115-4D17-8C9F-97FA85833BF8Q30238774-B9C67A48-2C2E-4F11-8FA7-6B3FC2EF3671Q30300875-31243CC5-7AC2-474E-9069-69DD76BB8F2FQ30557139-F715389C-77B3-433A-AAC4-EF347A9A05DCQ30910857-E449EF69-96E7-4A89-B74C-B8C91058F356Q33689894-DCD96D74-F71F-454D-9D57-1FAD7A5F7FD4Q33729659-A5A1CCD3-F899-4E00-B5FD-1E1737FF861FQ33817900-FE8219F8-14B1-442A-B263-0338837FA5BAQ33829804-62E5DFDA-657B-40A0-B5F2-F72F18758FA4Q33832923-A89C778E-29A3-4F3C-9BBA-9F7707A326C0Q33835535-4F69899B-B4A5-4A15-8774-BCD787633AD6Q33856320-3C5280DA-C76F-4C43-AD32-63C9E3167D3BQ34000877-0713AEC5-8551-40F0-B320-1E481E65B1CAQ34047033-BED418FE-3DA1-4625-9AFD-1A4013573E5DQ34121303-70C8D401-B181-4E48-984C-BC1870E0889FQ34156270-280FAB7C-7E13-4799-87E1-11BC0F493D9BQ34243496-EFF4F8E9-2B9C-463E-860C-B4CA2267D876Q34255849-42DF864B-DA0B-4261-8B13-7CD7820509FEQ34361198-D309C997-D8CD-4B57-A862-B60ABB304D3BQ34515586-7B960E53-FA5A-4911-A808-AD98CEB436B6Q34519918-83EE2B24-DFA5-4CE6-ABF7-09507FBA44ADQ34526631-47CA1165-D4D8-45E8-AECB-ABAB2CA875CDQ34582031-83ADF10B-109B-4F1D-8BEB-BEB072536B49Q34602508-997106DF-5D12-4A64-A7C9-FD3BE16475F8Q34718177-01759863-6B7D-4D22-ABF0-E1C6D4EC76BBQ34744623-C738B1AB-E6DB-4B22-804A-48C886D83D8DQ34786260-FB405FD4-EBAA-48C4-8DE0-268C7603E46BQ34960621-F191852D-7240-4C23-AA25-330A5ADDC43A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wylie Burke
@ast
Wylie Burke
@en
Wylie Burke
@es
Wylie Burke
@nl
Wylie Burke
@sl
type
label
Wylie Burke
@ast
Wylie Burke
@en
Wylie Burke
@es
Wylie Burke
@nl
Wylie Burke
@sl
prefLabel
Wylie Burke
@ast
Wylie Burke
@en
Wylie Burke
@es
Wylie Burke
@nl
Wylie Burke
@sl
P106
P31
P496
0000-0003-2914-0560